• Exchange: ASE
  • Sector: Health Care
  • Industry: Medical Equipment/Devices
  • Sub-Industry: Medical Equipment

Pharmaxis Ltd

+ Add to Watchlist

PXS:AU

0.0910 AUD 0.00000.00%

As of 02:10:32 ET on 04/16/2014.

Snapshot for Pharmaxis Ltd (PXS)

Open: 0.0910 Day's Range: 0.0910 - 0.0950 Volume: 226,736
Previous Close: 0.0910 52wk Range: 0.0900 - 0.3200 1-Yr Rtn: -69.67%

Stock Chart for PXS

No chart data available.
  • PXS:AU 0.0910
  • 1D
  • 1M
  • 1Y
0.0910
Interactive PXS Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for PXS

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) -
Relative P/E vs. AS51 -
Earnings Per Share (AUD) (ttm) -0.1405
Est. EPS (AUD) (06/2014) -0.0920
Est. PEG Ratio -
Market Cap (M AUD) 28.17
Shares Outstanding (M) 309.51
30 Day Average Volume 437,359
Price/Book (mrq) 0.5821
Price/Sale (ttm) 6.6925
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 04/16/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for PXS

  • Revenue
  • Net Income (M/AUD)
  • Profit Margin (%)

Company Profile & Key Executives for PXS

Pharmaxis Ltd. is a pharmaceutical company which develops therapeutic products for the human chronic respiratory and autoimmune diseases. The Company operates in Australia.

Gary Jonathan PhillipsChief Executive OfficerDavid Morris McGarveyCFO/Secretary
Howard George FoxChief Medical OfficerBrett CharltonDirector:Medical/Co-Founder
More Company Profile & Key Executives for PXS

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil